PALO ALTO, CA--(Marketwired - Apr 3, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced interim results of a registry study examining the ...
90.52% (n = 3, 094) of DermTech PLA registry study test results were negative for melanoma and 9.49% (n = 324) were positive. There is no difference in how board certified dermatologists and other ...